Literature DB >> 11790982

Adrenal incidentalomas.

Jérôme Bertherat1, Helen Mosnier-Pudar, Xavier Bertagna.   

Abstract

The term adrenal incidentaloma refers to an adrenal mass occasionally and unexpectedly discovered by an abdominal imaging procedure performed for reasons a priori unrelated to adrenal dysfunction. The prevalence of adrenal incidentalomas as discovered by computed tomographic scan examination is estimated to be between 1% and 4%. The vast majority of these lesions are of adrenocortical origin, most often adenomas. Identification of steroid or catecholamine-secreting tumors is important but usually solved with appropriate endocrinologic investigations. A difficult problem, however, is to distinguish between benign and malignant primary or secondary tumors. Size less than 4 cm and an unenhanced computed tomographic attenuation under 10 Hounsfield Units (HU) are findings in favor of a benign adrenocortical adenoma, as is a positive NP 59 scintigraphic examination. The pathogenesis of adrenal tumors is not well understood. However, alterations of the cyclic AMP signalling pathway have recently been observed in benign adrenocortical lesions and molecular defects associated with insulin-like growth factor-II overexpression in malignant adrenocortical tumors.

Entities:  

Mesh:

Year:  2002        PMID: 11790982     DOI: 10.1097/00001622-200201000-00011

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  16 in total

Review 1.  Review paper: origin and molecular pathology of adrenocortical neoplasms.

Authors:  M Bielinska; H Parviainen; S Kiiveri; M Heikinheimo; D B Wilson
Journal:  Vet Pathol       Date:  2009-03       Impact factor: 2.221

2.  Adrenal lesions in acromegaly: do metabolic aspects and aryl hydrocarbon receptor interacting protein gene have a role? Evaluation at baseline and after long-term follow-up.

Authors:  F Ceccato; G Occhi; N M Albiger; S Rizzati; S Ferasin; G Trivellin; F Mantero; C Scaroni
Journal:  J Endocrinol Invest       Date:  2010-07-01       Impact factor: 4.256

3.  GATA4 is a critical regulator of gonadectomy-induced adrenocortical tumorigenesis in mice.

Authors:  Justyna Krachulec; Melanie Vetter; Anja Schrade; Ann-Kathrin Löbs; Malgorzata Bielinska; Rebecca Cochran; Antti Kyrönlahti; Marjut Pihlajoki; Helka Parviainen; Patrick Y Jay; Markku Heikinheimo; David B Wilson
Journal:  Endocrinology       Date:  2012-03-28       Impact factor: 4.736

4.  Differentiation of adrenal adenoma and nonadenoma in unenhanced CT: new optimal threshold value and the usefulness of size criteria for differentiation.

Authors:  Sung Hee Park; Myeong-Jin Kim; Joo Hee Kim; Joon Seok Lim; Ki Whang Kim
Journal:  Korean J Radiol       Date:  2007 Jul-Aug       Impact factor: 3.500

5.  Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism?

Authors:  F Orio; S Palomba; T Cascella; L Tauchmanovà; S Di Biase; D Labella; T Russo; M Pellicano; S Savastano; F Zullo; G Lombardi; A Colao
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

6.  Expression of Wnt and TGF-β pathway components and key adrenal transcription factors in adrenocortical tumors: association to carcinoma aggressiveness.

Authors:  Helka Parviainen; Anja Schrade; Sanne Kiiveri; Renata Prunskaite-Hyyryläinen; Caj Haglund; Seppo Vainio; David B Wilson; Johanna Arola; Markku Heikinheimo
Journal:  Pathol Res Pract       Date:  2013-06-21       Impact factor: 3.250

Review 7.  The 'omics' of adrenocortical tumours for personalized medicine.

Authors:  Guillaume Assié; Anne Jouinot; Jérôme Bertherat
Journal:  Nat Rev Endocrinol       Date:  2014-02-04       Impact factor: 43.330

8.  18F-FDG PET/CT in the characterization and surgical decision concerning adrenal masses: a prospective multicentre evaluation.

Authors:  Catherine Ansquer; Sonia Scigliano; Eric Mirallié; David Taïeb; Laurent Brunaud; Fredéric Sebag; Christophe Leux; Delphine Drui; Benoît Dupas; Karine Renaudin; Françoise Kraeber-Bodéré
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-05-19       Impact factor: 9.236

9.  Clinical and genetic features of patients with multiple endocrine tumors who have neither family history nor MEN1 germline mutations.

Authors:  Akihiro Sakurai; Miyuki Katai; Wataru Yumita; Kesami Minemura; Kiyoshi Hashizume
Journal:  Endocrine       Date:  2004-02       Impact factor: 3.633

10.  Adrenal gland tumorigenesis after gonadectomy in mice is a complex genetic trait driven by epistatic loci.

Authors:  Sophie Bernichtein; Enrico Petretto; Stacey Jamieson; Anuj Goel; Timothy J Aitman; Jonathan M Mangion; Ilpo T Huhtaniemi
Journal:  Endocrinology       Date:  2007-11-15       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.